Premium
Randomised clinical trial: high‐dose vs. standard‐dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
Author(s) -
Chen C.C.,
Lee J.Y.,
Fang Y.J.,
Hsu S.J.,
Han M.l.,
Tseng P.H.,
Liou J.M.,
Hu F.C.,
Lin T.l.,
Wu M.S.,
Wang H.P.,
Lin J.T.
Publication year - 2012
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/j.1365-2036.2012.05047.x
Subject(s) - medicine , pantoprazole , regimen , peptic , gastroenterology , lansoprazole , hazard ratio , confidence interval , upper gastrointestinal bleeding , surgery , bolus (digestion) , helicobacter pylori , endoscopy , omeprazole , peptic ulcer
The optimal dosage of intravenous proton pump inhibitors (PPIs) for the prevention of peptic ulcer rebleeding remains unclear.